Vegfr-1 antibodies to treat breast cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 41/00 (2006.01) A61K 51/00 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2453474

The present invention is directed to methods of inhibiting tumor cells by administering an antagonist which inhibits the VEGF/VEGFR-1 autocrine loop of tumor cells. Additional antagonists can be added to inhibit endothelial paracrine loop by inhibiting other VEGFRs expressed on endothelial cells, particularly VEGFR-2. Examples of antagonists include antibodies and small molecules. A preferred cancer for treatment is breast cancer.

L'invention concerne des procédés pour inhiber des cellules tumorales par administration d'un antagoniste qui inhibe la boucle autocrine VEGF/VEGFR-1 de cellules tumorales. Il est possible d'ajouter des antagonistes supplémentaires pour inhiber la boucle paracrine endothéliale par inhibition d'autres récepteurs VEGFR exprimés dans des cellules endothéliales, notamment du récepteur VEGFR-2. Des exemples d'antagonistes incluent des anticorps et des petites molécules. Ces anticorps conviennent de préférence au traitement du cancer du sein.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vegfr-1 antibodies to treat breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vegfr-1 antibodies to treat breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vegfr-1 antibodies to treat breast cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1610159

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.